185 related articles for article (PubMed ID: 15267235)
21. New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Cirauqui N; Ceras J; Galiano S; Pérez-Silanes S; Juanenea L; Rivera G; Aldana I; Monge A
Arzneimittelforschung; 2008; 58(11):585-91. PubMed ID: 19137910
[TBL] [Abstract][Full Text] [Related]
22. Biological examination of melanin concentrating hormone receptor 1: multi-tasking from the hypothalamus.
Rokosz LL; Hobbs DW
Drug News Perspect; 2006 Jun; 19(5):273-86. PubMed ID: 16941049
[TBL] [Abstract][Full Text] [Related]
23. Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.
Souers AJ; Gao J; Brune M; Bush E; Wodka D; Vasudevan A; Judd AS; Mulhern M; Brodjian S; Dayton B; Shapiro R; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
J Med Chem; 2005 Mar; 48(5):1318-21. PubMed ID: 15743174
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1).
Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA
Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757
[TBL] [Abstract][Full Text] [Related]
25. Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists.
Giordanetto F; Karlsson O; Lindberg J; Larsson LO; Linusson A; Evertsson E; Morgan DG; Inghardt T
Bioorg Med Chem Lett; 2007 Aug; 17(15):4232-41. PubMed ID: 17532215
[TBL] [Abstract][Full Text] [Related]
26. Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists.
Palani A; Shapiro S; McBriar MD; Clader JW; Greenlee WJ; O'Neill K; Hawes B
Bioorg Med Chem Lett; 2005 Dec; 15(23):5234-6. PubMed ID: 16202583
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.
Vasudevan A; Wodka D; Verzal MK; Souers AJ; Gao J; Brodjian S; Fry D; Dayton B; Marsh KC; Hernandez LE; Ogiela CA; Collins CA; Kym PR
Bioorg Med Chem Lett; 2004 Oct; 14(19):4879-82. PubMed ID: 15341943
[TBL] [Abstract][Full Text] [Related]
28. Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists.
Meyers KM; Méndez-Andino J; Colson AO; Hu XE; Wos JA; Mitchell MC; Hodge K; Howard J; Paris JL; Dowty ME; Obringer CM; Reizes O
Bioorg Med Chem Lett; 2007 Feb; 17(3):657-61. PubMed ID: 17174091
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: a novel class of potent MCH-R1 antagonists.
Méndez-Andino JL; Colson AO; Meyers KM; Mitchell MC; Hodge K; Howard JM; Kim N; Ackley DC; Holbert JK; Mittelstadt SW; Dowty ME; Obringer CM; Suchanek P; Reizes O; Hu XE; Wos JA
Bioorg Med Chem; 2007 Mar; 15(5):2092-105. PubMed ID: 17236777
[TBL] [Abstract][Full Text] [Related]
30. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
[TBL] [Abstract][Full Text] [Related]
31. Identification of 4-amino-2-cyclohexylaminoquinazolines as metabolically stable melanin-concentrating hormone receptor 1 antagonists.
Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Nagase Y; Iida I; Yamaguchi J; Semple G; Tran TA; Sekiguchi Y
Bioorg Med Chem; 2006 May; 14(10):3307-19. PubMed ID: 16434202
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1.
Souers AJ; Wodka D; Gao J; Lewis JC; Vasudevan A; Gentles R; Brodjian S; Dayton B; Ogiela CA; Fry D; Hernandez LE; Marsh KC; Collins CA; Kym PR
Bioorg Med Chem Lett; 2004 Oct; 14(19):4873-7. PubMed ID: 15341942
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R.
Sailer AW; Sano H; Zeng Z; McDonald TP; Pan J; Pong SS; Feighner SD; Tan CP; Fukami T; Iwaasa H; Hreniuk DL; Morin NR; Sadowski SJ; Ito M; Ito M; Bansal A; Ky B; Figueroa DJ; Jiang Q; Austin CP; MacNeil DJ; Ishihara A; Ihara M; Kanatani A; Van der Ploeg LH; Howard AD; Liu Q
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7564-9. PubMed ID: 11404457
[TBL] [Abstract][Full Text] [Related]
35. Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.
Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Sekiguchi Y
Bioorg Med Chem Lett; 2005 Sep; 15(17):3853-6. PubMed ID: 16002290
[TBL] [Abstract][Full Text] [Related]
36. Prospects for obesity treatment: MCH receptor antagonists.
Collins CA; Kym PR
Curr Opin Investig Drugs; 2003 Apr; 4(4):386-94. PubMed ID: 12808876
[TBL] [Abstract][Full Text] [Related]
37. Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture.
Ahnaou A; Drinkenburg WH; Bouwknecht JA; Alcazar J; Steckler T; Dautzenberg FM
Eur J Pharmacol; 2008 Jan; 579(1-3):177-88. PubMed ID: 18062961
[TBL] [Abstract][Full Text] [Related]
38. 2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.
Jiang J; Hoang M; Young JR; Chaung D; Eid R; Turner C; Lin P; Tong X; Wang J; Tan C; Feighner S; Palyha O; Hreniuk DL; Pan J; Sailer AW; MacNeil DJ; Howard A; Shearman L; Stribling S; Camacho R; Strack A; Van der Ploeg LH; Goulet MT; DeVita RJ
Bioorg Med Chem Lett; 2006 Oct; 16(20):5270-4. PubMed ID: 16919456
[TBL] [Abstract][Full Text] [Related]
39. Biological diversity from a structurally diverse library: systematically scanning conformational space using a pyranose scaffold.
Abbenante G; Becker B; Blanc S; Clark C; Condie G; Fraser G; Grathwohl M; Halliday J; Henderson S; Lam A; Liu L; Mann M; Muldoon C; Pearson A; Premraj R; Ramsdale T; Rossetti T; Schafer K; Le Thanh G; Tometzki G; Vari F; Verquin G; Waanders J; West M; Wimmer N; Yau A; Zuegg J; Meutermans W
J Med Chem; 2010 Aug; 53(15):5576-86. PubMed ID: 20684600
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents.
Warshakoon NC; Sheville J; Bhatt RT; Ji W; Mendez-Andino JL; Meyers KM; Kim N; Wos JA; Mitchell C; Paris JL; Pinney BB; Reizes O; Hu XE
Bioorg Med Chem Lett; 2006 Oct; 16(19):5207-11. PubMed ID: 16870427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
